Lung Cancer Mortality Risk in Patients with Breast Cancer Treated with Antiestrogens
Efficacy of Administering Preoperative Hydroxyprogesterone in Women with Operable Breast Cancer
Outcomes of Women Who Were Premenopausal at Diagnosis in the MA17 Trial of Extended Letrozole After Five Years of Tamoxifen
Effect of High-Dose Vitamin D Therapy on Bone Mineral Density and Anastrozole-Induced Musculoskeletal Pain
Oral Bisphosphonates and Breast Cancer — Prospective Results from the Women’s Health Initiative (WHI)
Effect of Obesity on Prognosis After Early Breast Cancer
Cardiac Safety Results of a Docetaxel/Cyclophosphamide/Trastuzumab Combination in Patients with HER2-Positive Early-Stage Breast Cancer
Assessment of the Prognostic Role of HER2 Overexpression in Patients with Node-Negative, pT1a-b Breast Cancer
Updated Survival Analysis of the EGF104900 Randomized Study of Lapatinib Alone or Combined with Trastuzumab for HER2-Positive Breast Cancer Progressing on Trastuzumab
Molecular Characterization of Breast Cancer Core Biopsy Specimens by RT-PCR Gene Expression Analysis
Effect of a 21-Gene RT-PCR Assay on Treatment Recommendations for Patients with Node-Positive, ER-Positive Breast Cancer
Prognostic and Predictive Value of the 21-Gene Recurrence Score® for Women with Node-Positive Breast Cancer Receiving Chemotherapy
Tyrosine Kinases as Targets for Cancer Therapy
Sunitinib versus Capecitabine for Patients with HER2-Negative Advanced Breast Cancer
SOLTI-0701 — A Double-Blind, Randomized Phase IIb Study of Capecitabine with or without Sorafenib in Advanced Breast Cancer